window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 13, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug Discovery & Development

  • Advanced Therapies,Drug Discovery & Development,Manufacturing & Supply Chain

    Lonza expands bioconjugate capabilities at Oss site to support ADC development

    Lonza expands its Advanced Synthesis capabilities at Oss, integrating ADC [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    Evinova secures collaborations with Astellas, AstraZeneca and Bristol Myers Squibb to share clinical trial data for AI benchmarking

    Evinova has announced collaborations with Astellas Pharma, AstraZeneca and Bristol [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Therapeutic Areas

    Evogene partners QUT on AI drug discovery for lung cancer resistance

    Evogene Ltd has partnered with Queensland University of Technology to [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Therapeutic Areas

    Axol Bioscience acquires Newcells ophthalmology business to expand retinal organoid portfolio

    Axol Bioscience has acquired the ophthalmology business of Newcells Biotech, [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Polaryx therapeutics selects contract research organization for SOTERIA phase 2 basket trial

    Polaryx Therapeutics, Inc has selected a leading contract research organization [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    ViiV Healthcare highlights ultra long-acting HIV pipeline and Phase 1 data at CROI 2026

    ViiV Healthcare will present new data from its long-acting and [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development,Pharmaceuticals and therapeutics

    Within3 launches Dataverse to integrate real-world data into pharma launch intelligence platform

    Within3 has launched Dataverse, a partner ecosystem designed to extend [...]

    May 5, 2026
  • Drug Delivery & Formulation,Drug Discovery & Development,Manufacturing & Supply Chain

    DFE Pharma launches continuous manufacturing platform with Gericke to support formulation development

    DFE Pharma has launched a new continuous manufacturing platform in [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Pharmaceuticals and therapeutics

    AI and medical affairs strategy set to redefine life sciences in 2026

    Artificial intelligence, shifting healthcare professional behaviour and rising pressure on [...]

    May 5, 2026
  • Drug Discovery & Development,Manufacturing & Supply Chain,Opinion & Events

    HORIBA to build new global headquarters to strengthen operations and drive innovation

    HORIBA, Ltd., a global leader in analytical and measurement instrumentation [...]

    May 5, 2026
Previous8910Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • ProQR partners with Ginkgo Bioworks for AI-driven RNA editing development and forms advisory board
    Categories: Biotech & Pharma Business, Digital & Data, Drug Discovery & Development
  • Weite Oldenziel
    Ofichem unifies CDMO and pharmaceutical supply brands under single identity
    Categories: Manufacturing & Supply Chain
  • DeepCyte raises $1.5M to advance single-cell AI toxicology platform for drug development
    Categories: Biotech & Pharma Business, Digital & Data, Drug Discovery & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top